EXPERIENCE WITH THE NEW DIRECT ACTING ANTIVIRAL AGENTS IN A THIRD LEVEL HOSPITAL IN 2018 (submitted in 2019)
4CPS-266
Clone of ANALYSIS OF AN EPIDEMIOLOGICAL MODEL FOR THE TREATMENT OF HEPATITIS C VIRUS IN CO-INFECTED HIV/HCV DRUG ADDICTIONS VIA PARENTERAL
4CPS-284
BINARY LOGISTIC REGRESSION ANALYSIS TO EVALUATE THE INFLUENCE OF DIFFERENT BASAL FACTORS ON THE EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR
4CPS-283
ABSTRACT WITHDRAWN
4CPS-282
ABSTRACT WITHDRAWN
4CPS-281
A COMPARATIVE STUDY OF THE SATISFACTION OF CLIENTS WITH THE SERVICES OF AN OUTPATIENT PHARMACY IN A TERTIARY HOSPITAL
4CPS-280
DOES PLATELET-RICH PLASMA COMPOSITION MATTER IN HIP OSTEOARTHRITIS?
4CPS-279
THE EFFECT OF CONTINUATION OF HOME MEDICATION BY HOSPITALISED PATIENTS ON MEDICATION WASTE AND PATIENT SATISFACTION, A MULTICENTRE, QUASI-EXPERIMENTAL STUDY WITH A PRE-POST DESIGN
4CPS-278
ABSTRACT WITHDRAWN
4CPS-277
ABSTRACT WITHDRAWN
4CPS-276
ANTIMICROBIAL STEWARDSHIP PROGRAMME IMPLEMENTATION IN THE GULF COOPERATION COUNCIL STATES: A SYSTEMATIC REVIEW
4CPS-275
A SYSTEMATIC REVIEW OF PHARMACIST INPUT IN THE SCREENING, MANAGEMENT AND PREVENTION OF METABOLIC SYNDROME
4CPS-274
ABSTRACT WITHDRAWN
4CPS-273
PHARMACY INTERVENTION AND DRUG PRESCRIPTION REGULATIONS IN A TERTIARY HOSPITAL
4CPS-272
ANALYSIS OF ADVERSE REACTION REPORTS BEFORE AND AFTER THE USE OF EQUIVALENT IMATINIB IN A TERTIARY HOSPITAL
